Word

Status

Pending

Status Code

688

Status Date

Tuesday, November 14, 2023

Serial Number

97672483

Mark Type

2000

Filing Date

Thursday, November 10, 2022

Published for Opposition

Tuesday, September 19, 2023

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

The mark consists of 3 lines in the color of gold, aqua and slate that are stretched horizontally in opposite directions as the lines thin in the center.
The color(s) slate, aqua, gold is/are claimed as a feature of the mark.

Trademark Events

Nov 14, 2023

Noa E-Mailed - Sou Required From Applicant

Sep 19, 2023

Official Gazette Publication Confirmation E-Mailed

Sep 19, 2023

Published For Opposition

Aug 30, 2023

Notification Of Notice Of Publication E-Mailed

Aug 16, 2023

Approved For Pub - Principal Register

Aug 14, 2023

Assigned To Examiner

Dec 2, 2022

Notice Of Design Search Code E-Mailed

Dec 1, 2022

New Application Office Supplied Data Entered

Nov 14, 2022

New Application Entered